BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 99362)

  • 21. GH regulation in acromegaly.
    Liuzzi A; Oppizzi G; Cozzi R; Dallabonzana D; Petroncini M; Orlandi P; Chiodini PG
    J Pediatr Endocrinol; 1993; 6(3-4):339-43. PubMed ID: 7921003
    [No Abstract]   [Full Text] [Related]  

  • 22. [Differences in autonomy of the growth hormone secretion in patients with acromegaly (author's transl)].
    Hanew K
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):25-37. PubMed ID: 105940
    [No Abstract]   [Full Text] [Related]  

  • 23. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspects of the mechanism of action of hypothalamic releasing hormones in the anterior pituitary gland.
    Labrie F; Pelletier G; Barden N
    Adv Sex Horm Res; 1975; 1():77-127. PubMed ID: 178161
    [No Abstract]   [Full Text] [Related]  

  • 25. New options for diagnosing and treating acromegaly.
    Barkan AL
    Cleve Clin J Med; 1998; 65(7):343, 347-9. PubMed ID: 9679389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dopamine and pituitary hormones. Physiology and pathology (author's transl)].
    Saltiel H; Thomopoulos P
    Ann Endocrinol (Paris); 1981 Dec; 42(6):497-516. PubMed ID: 6285797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GHRF test in acromegalic patients for the evaluation of therapeutic results.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1985 Nov; 147(3):273-80. PubMed ID: 3937295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly.
    Hanew K; Kokubun M; Sasaki A; Mouri T; Yoshinaga K
    J Clin Endocrinol Metab; 1980 Aug; 51(2):292-7. PubMed ID: 6772662
    [No Abstract]   [Full Text] [Related]  

  • 29. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
    Looij BJ; Nieuwenhuijzen Kruseman AC; Mudde AH; Frölich M; Piaditis GP; Hodgkinson SC; McLean C; Grossman A; Coy DH; Rees LH
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):149-56. PubMed ID: 2871949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthyroidism and acromegaly due to a thyrotropin- and growth hormone-secreting pituitary tumor. Lack of hormonal response to bromocriptine.
    Carlson HE; Linfoot JA; Braunstein GD; Kovacs K; Young RT
    Am J Med; 1983 May; 74(5):915-23. PubMed ID: 6340497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
    Lamberts SW; Klijn JG; Kwa GH; Birkenhäger JC
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):198-210. PubMed ID: 105530
    [No Abstract]   [Full Text] [Related]  

  • 32. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction.
    Chung KF; Alaghband-Zadeh J; Guz A
    Am J Dis Child; 1983 Feb; 137(2):134-6. PubMed ID: 6401383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actions of releasing factors on isolated secretory granules mediated by calcium.
    Dular R; LaBella F
    Life Sci; 1977 Nov; 21(10):1527-34. PubMed ID: 412029
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cure and quiescent period in acromegaly. Long-term results of surgery or radiotherapy].
    Barreiro N; Velasco F; Mora R; Larraza O; Fanghanel G; Hernández M; García-Reyes JA; Valverde C
    Rev Invest Clin; 1982; 34(4):321-6. PubMed ID: 6820540
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical experience with hypothalamic releasing hormones. 1. Thyrotropin-releasing hormone.
    Gual C; Kastin AJ; Schally AV
    Recent Prog Horm Res; 1972; 28():173-200. PubMed ID: 4631752
    [No Abstract]   [Full Text] [Related]  

  • 36. Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion.
    Lamberg BA; Kivikangas V; Vartianen J; Raitta C; Pelkonen R
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):267-81. PubMed ID: 818860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of involvement of the cholinergic mechanism in vasoactive intestinal peptide- and peptide-histidine methionine-induced growth hormone (GH) responses in acromegaly: comparison with the GH responses to thyrotropin-releasing hormone and GH-releasing hormone.
    Watanobe H; Habu S; Nasushita R; Takebe K
    Neuropeptides; 1994 Aug; 27(2):85-90. PubMed ID: 7991070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extrapituitary acromegaly.
    Melmed S
    Endocrinol Metab Clin North Am; 1991 Sep; 20(3):507-18. PubMed ID: 1935918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery.
    Schaison G; Couzinet B; Moatti N; Pertuiset B
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):541-9. PubMed ID: 6411389
    [No Abstract]   [Full Text] [Related]  

  • 40. Applications of adenohypophyseal cell cultures to neuroendocrine studies.
    Vale W; Rivier C; Brown M; Chan L; Ling N; Rivier J
    Curr Top Mol Endocrinol; 1976; 3():397-429. PubMed ID: 28908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.